
MediPal Holdings Corporation
7459.TJPXHealthcareMedical - Distribution
Latest quote
¥2,904.5
−¥13.50 · -0.46%
7459.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteMedipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
- Industry
- Medical - Distribution
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Shuichi Watanabe
- Listed since
- Jan 1, 2001
- Employees
- 13,024
Market position
- Volume
- 196.3K
- 0.47× average
- Average volume
- 419.69K
- Average daily volume
- Market cap
- 594.44B JPY
- Beta
- -0.02
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 315.58B JPY
- P/E (TTM)
- 12.78×
- P/B (TTM)
- 0.91×
- P/S (TTM)
- 0.15×
- EV / EBITDA
- 2.87×
- Earnings yield
- 7.03%
- Free cash flow yield
- 6.60%
- Dividend yield
- 2.27%
Profitability & efficiency
- Gross margin
- 6.43%
- Operating margin
- 1.36%
- Net margin
- 1.21%
- Return on equity
- 6.52%
- Return on assets
- 2.21%
- Return on invested capital
- 4.04%
Financial health
- Debt / equity
- 0.07×
- Current ratio
- 1.28×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 3.82T JPY | 3.67T JPY | 3.56T JPY | 3.36T JPY | 3.29T JPY |
| Cost of goods sold | 3.57T JPY | 3.43T JPY | 3.33T JPY | 3.15T JPY | 3.09T JPY |
| Gross profit | 247.41B JPY | 242.25B JPY | 233.01B JPY | 212.12B JPY | 205.11B JPY |
| Research and development | — | 1.42B JPY | 991M JPY | 103M JPY | 108M JPY |
| Selling, general, and administrative | 194.22B JPY | 186.63B JPY | 185.68B JPY | 163.04B JPY | 159.38B JPY |
| Operating expenses | 194.22B JPY | 186.63B JPY | 185.68B JPY | 163.14B JPY | 159.49B JPY |
| Interest income | 234M JPY | 50M JPY | 29M JPY | 101M JPY | 177M JPY |
| Interest expense | 13M JPY | 7M JPY | 8M JPY | 34M JPY | 16M JPY |
| Depreciation and amortization | 28.19B JPY | 18.42B JPY | 17.98B JPY | 14.65B JPY | 14.34B JPY |
| Operating income | 53.18B JPY | 55.61B JPY | 47.33B JPY | 48.97B JPY | 45.63B JPY |
| Net income | 42.54B JPY | 40.28B JPY | 41.48B JPY | 38.81B JPY | 29.42B JPY |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 73%
- 8 beats, 3 misses, 0 met estimates
- Average EPS surprise
- +25.44%
- 11 comparable reports
- Latest EPS result
- 66.66
- Estimate 44.91 · Beat by 48.43%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
7459.T peers
ETFs holding 7459.T
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T1.68B0.06%2.89T JPY0.05%¥418.4+0.10%
iShares JPX-Nikkei 400 ETF1364.T493.64M0.08%592.34B JPY0.05%¥3,767+0.16%
Vanguard Total International Stock ETFVXUS50.59M0.01%646.2B USD0.05%$87.71+0.78%
Vanguard FTSE Developed Markets ETFVEA33.03M0.01%315B USD0.03%$73.42+0.80%
iShares Core MSCI EAFE ETFIEFA23.47M0.01%195.14B USD0.07%$100.85+0.86%
State Street SPDR Portfolio Developed World ex-US ETFSPDW14.32M0.03%41.92B USD0.03%$52.02+0.79%
iShares MSCI EAFE Small-Cap ETFSCZ11.93M0.09%13.28B USD0.40%$86.60+0.70%
Schwab Fundamental International Large Company Index ETFFNDF10.77M0.04%26.15B USD0.25%$55.84+0.83%
iShares Core TOPIX ETF1475.T- Market value
- 1.68B
- Weight
- 0.06%
- AUM
- 2.89T JPY
- Expense ratio
- 0.05%
- Price / 1D
- ¥418.4+0.10%
iShares JPX-Nikkei 400 ETF1364.T- Market value
- 493.64M
- Weight
- 0.08%
- AUM
- 592.34B JPY
- Expense ratio
- 0.05%
- Price / 1D
- ¥3,767+0.16%
Vanguard Total International Stock ETFVXUS- Market value
- 50.59M
- Weight
- 0.01%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.71+0.78%
Vanguard FTSE Developed Markets ETFVEA- Market value
- 33.03M
- Weight
- 0.01%
- AUM
- 315B USD
- Expense ratio
- 0.03%
- Price / 1D
- $73.42+0.80%
iShares Core MSCI EAFE ETFIEFA- Market value
- 23.47M
- Weight
- 0.01%
- AUM
- 195.14B USD
- Expense ratio
- 0.07%
- Price / 1D
- $100.85+0.86%
State Street SPDR Portfolio Developed World ex-US ETFSPDW- Market value
- 14.32M
- Weight
- 0.03%
- AUM
- 41.92B USD
- Expense ratio
- 0.03%
- Price / 1D
- $52.02+0.79%
iShares MSCI EAFE Small-Cap ETFSCZ- Market value
- 11.93M
- Weight
- 0.09%
- AUM
- 13.28B USD
- Expense ratio
- 0.40%
- Price / 1D
- $86.60+0.70%
Schwab Fundamental International Large Company Index ETFFNDF- Market value
- 10.77M
- Weight
- 0.04%
- AUM
- 26.15B USD
- Expense ratio
- 0.25%
- Price / 1D
- $55.84+0.83%
Continue in GoAI
Research 7459.Tresearch.disclaimer





